###RELATED###Antibiotic growth promoters have long been widely used in farming to prevent disease and promote growth in livestock. In recent years, there has been growing pressure from consumers, governments and corporations alike to reduce the use of antibiotic growth promoters.
One promising alternative is probiotics – naturally-occurring live microorganisms that help improve the balance between good and bad bacteria in the gut.
“The world needs new solutions to feed a growing global population in a sustainable way. We’re developing probiotics that can help farmers meet that need."
Partnerships to strengthen offering and position
Novozymes entered the market for animal probiotics in 2015. In May, Novozymes and Adisseo, one of the world's leading experts in feed additives, announced a partnership to develop and market a probiotic for poultry. Novozymes is responsible for in-vitro screening, development and production, while Adisseo will handle in-vivo testing, marketing and sales. In October, Novozymes went on to acquire Pacific Vet Group-USA Inc. (PVG), a small U.S. company with significant know-how in application development in probiotics for poultry, expertise in technology development, and an existing commercial portfolio and pipeline.
The world needs new solutions to feed a growing global population in a sustainable way. We’re developing probiotics that can help farmers meet that need,” says Helle Warrer Poulsen, Vice President of Animal Health & Nutrition at Novozymes. “We’re excited to partner with Adisseo, who share our vision of bringing innovation and science to the field of probiotics and offer considerable expertise and capabilities in feed additives. It’s a promising new area for Novozymes where we can leverage our extensive know-how in microbiology, fermentation and animal feed.”
PVG is a great fit with Novozymes as we continue to build our position as the leading innovation partner in probiotics for animals. “They develop innovative microbial technology for poultry and have strong ties to academia and industry knowledge that will benefit Novozymes. On top of that, they have a promising pipeline that Novozymes can help mature and commercialize,” explains Warrer Poulsen.